Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09 First-quarter reported sales growth of 4.0 percent; organic sales growth of 6.9 percent or ...

Guidance: Abbott reaffirms full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.15, with organic sales growth ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

Designed to overcome limitations of existing systems, Abbott's Volt™ PFA System provides a new therapy option for people battling heart rhythm disorders. Sun Pharma to Acquire Checkpoint ...

West Ham United women’s team forward Viviane Asseyi has been nominated for the PFA WSL Fans’ Player of the Month award for March. The 31-year-old enjoyed another impressive few weeks for Rehanne ...

The authors acknowledged limitations to their study, including a potential lack of generalizability to other PFA systems, and a lack of baseline assessment of the burden of atrial fibrillation.

The ablation catheter manufacturing clean room at Abbott Labs in Plymouth in 2021. Abbott recently secured approval to market its new pulse field ablation device for atrial fibrillation in Europe ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...